Drugs View Homepage


Ontology type: schema:Periodical     


Journal Info

START YEAR

1971

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

http://link.springer.com/journal/40265

Recent publications latest 20 shown

  • 2021-10-27 Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
  • 2021-10-25 Vosoritide: First Approval
  • 2021-10-23 Correction to: Sotorasib: First Approval
  • 2021-10-23 Correction to: Contezolid: First Approval
  • 2021-10-21 Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study
  • 2021-10-21 Difelikefalin: First Approval
  • 2021-10-18 Disitamab Vedotin: First Approval
  • 2021-10-11 Correction to: Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
  • 2021-10-09 The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
  • 2021-10-08 Bimekizumab for the Treatment of Psoriasis
  • 2021-10-06 Belzutifan: First Approval
  • 2021-10-01 Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
  • 2021-09-30 Donafenib: First Approval
  • 2021-09-30 Avalglucosidase alfa: First Approval
  • 2021-09-29 REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study
  • 2021-09-29 Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
  • 2021-09-24 Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
  • 2021-09-24 Correction to: Tralokinumab: First Approval
  • 2021-09-23 Anifrolumab: First Approval
  • 2021-09-23 Correction to: Odevixibat: First Approval
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "1.6920000314712524", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "1.5889999866485596", 
            "type": "Rating"
          }
        ], 
        "description": "

    Stay up to date with the latest developments in therapeutics by reading the world\u2019s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international clinicians and researchers to support clinical decision-making.\u00a0\u00a0\u00a0

    Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.

    Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal\u2019s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager\u00ae, supported by a database of international experts. This database is shared with other Adis journals.

    There are no publication charges for standard publishing in Drugs; the journal offers the option of Open Access publication via Springer Open Choice (article processing charge \u20ac3,060 / US$3,860). Please click on the link below under \u2018Publishing model\u2019 for further information about this service.

    ", "editor": [ { "familyName": "Peters", "givenName": "Dene", "type": "Person" } ], "id": "sg:journal.1084788", "inLanguage": [ "en" ], "isAccessibleForFree": false, "issn": [ "0012-6667", "1179-1950" ], "license": "Hybrid (Open Choice)", "name": "Drugs", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "84788" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "71-612913" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "7600076" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "439975" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "14747" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Adis", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1084788" ], "sdDataset": "journals", "sdDatePublished": "2021-11-01T19:07", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/journal/journal_0.jsonl", "startYear": "1971", "type": "Periodical", "url": "http://link.springer.com/journal/40265" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1084788'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1084788'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1084788'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1084788'


     

    This table displays all metadata directly associated to this object as RDF triples.

    60 TRIPLES      20 PREDICATES      27 URIs      23 LITERALS      10 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1084788 schema:contentRating N8304baa3f747453f85bf182e995637e5
    2 Nbecbae18471d4e588d163f1c08c6b4f5
    3 schema:description <p>Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years <i>Drugs</i> has been the definitive journal of drugs and therapeutics, promoting optimum pharmacotherapy by publishing reviews and original research authored by leading international clinicians and researchers to support clinical decision-making.    </p><p>Through a rigorous and comprehensive program of peer-reviewed evaluations, <i>Drugs</i> provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.</p><p><i>Drugs</i> offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.</p><p>There are no publication charges for standard publishing in <i>Drugs</i>; the journal offers the option of Open Access publication via Springer Open Choice (article processing charge €3,060 / US$3,860<b>)</b>. Please click on the link below under ‘Publishing model’ for further information about this service.</p>
    4 schema:editor Na27599903d964a75adacb035dd5f854a
    5 schema:inLanguage en
    6 schema:isAccessibleForFree false
    7 schema:issn 0012-6667
    8 1179-1950
    9 schema:license Hybrid (Open Choice)
    10 schema:name Drugs
    11 schema:productId N088194b43a33411382db0569e71aade4
    12 N18b32c5c81ed43129b6e805066827e86
    13 N2c8b6c0a8fb7429ca51f1a51d559f59a
    14 N540b4b6f9f4a4bd3b3fa1ee13cdb6b73
    15 Ndc5d8e56ff7243ffb09983a7d00aa706
    16 schema:publisher N0aabdaee937247bea607207c39cc22cf
    17 schema:publisherImprint Adis
    18 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1084788
    19 schema:sdDatePublished 2021-11-01T19:07
    20 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    21 schema:sdPublisher Nf4755e833ee645d6ba5f12532eab1848
    22 schema:startYear 1971
    23 schema:url http://link.springer.com/journal/40265
    24 sgo:license sg:explorer/license/
    25 sgo:sdDataset journals
    26 rdf:type schema:Periodical
    27 N088194b43a33411382db0569e71aade4 schema:name nsd_ids_id
    28 schema:value 439975
    29 rdf:type schema:PropertyValue
    30 N0aabdaee937247bea607207c39cc22cf schema:name Springer International Publishing
    31 rdf:type schema:Organization
    32 N18b32c5c81ed43129b6e805066827e86 schema:name dimensions_id
    33 schema:value 84788
    34 rdf:type schema:PropertyValue
    35 N2c8b6c0a8fb7429ca51f1a51d559f59a schema:name lccn_id
    36 schema:value 71-612913
    37 rdf:type schema:PropertyValue
    38 N540b4b6f9f4a4bd3b3fa1ee13cdb6b73 schema:name era_ids_id
    39 schema:value 14747
    40 rdf:type schema:PropertyValue
    41 N627b3bafe1a14917be9e65017d97d5f2 rdf:first snip
    42 rdf:rest rdf:nil
    43 N8304baa3f747453f85bf182e995637e5 schema:author N627b3bafe1a14917be9e65017d97d5f2
    44 schema:ratingValue 1.6920000314712524
    45 rdf:type schema:Rating
    46 Na27599903d964a75adacb035dd5f854a rdf:first Nb77fda17eb694dfb8aa158afec69d3e0
    47 rdf:rest rdf:nil
    48 Nad0ea0fd566b4ec586fef042e478ce4e rdf:first sjr
    49 rdf:rest rdf:nil
    50 Nb77fda17eb694dfb8aa158afec69d3e0 schema:familyName Peters
    51 schema:givenName Dene
    52 rdf:type schema:Person
    53 Nbecbae18471d4e588d163f1c08c6b4f5 schema:author Nad0ea0fd566b4ec586fef042e478ce4e
    54 schema:ratingValue 1.5889999866485596
    55 rdf:type schema:Rating
    56 Ndc5d8e56ff7243ffb09983a7d00aa706 schema:name nlm_unique_id
    57 schema:value 7600076
    58 rdf:type schema:PropertyValue
    59 Nf4755e833ee645d6ba5f12532eab1848 schema:name Springer Nature - SN SciGraph project
    60 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...